AS univation® XF NO163ZRecalls & reported problems
Aesculap AG · AS UNIVATION XF TIBIA CEMENTED T2 LM · Class 2 · Implant
All models of AS univation XF (14)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04046964053740), received between Nov 26, 2020 and Nov 26, 2020 — classified as 1 injury.
The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Ambulation or Postural Difficulties1
- Failure of Implant1
- Joint Disorder1
- Pain1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryNov 26, 2020Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth
UPDATE: (B)(6) 2016 PROCEDURE - LEFT KNEE MEDIAL UNICOMPARTMENTAL ARTHROPLASTY. NORMAL OPERATIVE COURSE. (PALACOS BONE CEMENT). (B)(6) 2017 PREOP DX: FAILED UNICOMPARTMENTAL TOTAL KNEE (PARTIAL KNEE) - NICKEL ALLERGY NOTED. INDICATIONS: SIGNIFICANT STIFFNESS AND PAIN, DEGENERATIVE CHANGES ON THE OTHER SIDE AND PATIENT HAS REQUESTED CONVERSION TO A TOTAL KNEE ARTHROPLASTY. HISTORY: CONSERVATIVE PAIN TREATMENTS HAVE FAILED; STEROID INJECTION IN THE OFFICE WITH TEMPORARY RELIEF; X-RAY RESULTS SHOWED NO OBVIOUS SIGNED OF LOOSENING, WEAR OR FAILURE. PROCEDURE: REVISION OF LEFT KNEE; REMOVAL OF PREVIOUS KNEE IMPLANT WITHOUT SIGNIFICANT BONE LOSS; REPLACED WITH NON-AESCULAP PRODUCTS. (B)(6) 2019 HOSPITAL ADMISSION FOR PROSTHESIS PAIN (IMAGING ORDER DIAGNOSIS - POSSIBLE INFECTION/INFLAMMATORY REACTION DUE TO INTERNAL PROSTHETIC DEVICE, IMPLANT, AND/OR GRAFT) - 2ND BONE SCAN. THE PATIENT IS CURRENTLY UNABLE TO WALK WITHOUT A LIMP AND DOES NOT HAVE FULL MOBILITY OF HER KNEE DUE TO CONTINUOUS SURGERIES AND SCAR TISSUE. THE PATIENT IS UNABLE TO RETURN TO WORK. ASSOCIATED MEDWATCH: 2916714-2020-00646, 2916714-2020-00702, 2916714-2020-00703.
Patient problems: Ambulation or Postural Difficulties; Failure of Implant; Joint Disorder; Pain
MAUDE report 10907823 ↗
Other PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices
- R3 71363077Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER461 reports
- NA 71364009Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER174 reports
- JOURNEY 74012415Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER163 reports
- JOURNEY 74012416Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER163 reports
- JOURNEY 74012414Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER129 reports
- GENESIS II 71440194Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER114 reports
- GENESIS II 71440842Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER113 reports
- JOURNEY 74018901Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER106 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page